OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models
- 1 May 2010
- journal article
- review article
- Published by Elsevier BV in Drug and Alcohol Dependence
- Vol. 108 (3), 172-182
- https://doi.org/10.1016/j.drugalcdep.2009.12.016
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- Suppression of Alcohol Preference by Naltrexone in the Rhesus Macaque: A Critical Role of Genetic Variation at the μ-Opioid Receptor Gene LocusBiological Psychiatry, 2010
- Variation in the μ-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejectionProceedings of the National Academy of Sciences of the United States of America, 2009
- Genetic variability of the μ-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women ☆Pain, 2008
- Nicotine abstinence-induced cerebral blood flow changes by genotypeNeuroscience Letters, 2008
- Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primatesProceedings of the National Academy of Sciences of the United States of America, 2008
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysisDrug and Alcohol Dependence, 2007
- Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT genePain, 2007
- μ Opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusersProceedings of the National Academy of Sciences of the United States of America, 2006
- Is there a common molecular pathway for addiction?Nature Neuroscience, 2005